Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The effect of leptin on blood pressure considering smoking status: a Mendelian randomization study

Hypertension Research volume 43, pages 342–349 (2020)Cite this article

Abstract

Studies on leptin and blood pressure (BP) associations have yielded inconsistent findings. The current study aimed to evaluate the effect of genetically determined leptin on BP and to explore whether smoking status modified this effect. We conducted a Mendelian randomization analysis using the baseline data of 3860 participants in the Framingham Heart Study 3rd generation cohort. Pairwise associations among leptin genetic risk score (GRS), log-transformed leptin (log-leptin), and BP were assessed by multivariate linear regression models. Age and sex were adjusted in the base model, and education, smoking, drinking, and physical activity were adjusted in the full model. The interaction between leptin GRS and smoking was evaluated by adding an interaction term, GRS × smoking, in the fully adjusted model. In the age- and sex-adjusted analyses, log-leptin was positively associated with systolic BP (SBP) (P = 2.35 × 10−79), diastolic BP (DBP) (P = 6.19 × 10−76), mean arterial pressure (MAP) (P = 1.10 × 10−90), and pulse pressure (P = 4.38 × 10−19). Leptin GRS significantly increased log-leptin (P = 0.00001). Leptin GRS was associated with reduced SBP (P = 0.04), DBP (P = 0.006), and MAP (P = 0.008) among current smokers. In the fully adjusted model, significant interactions between GRS and smoking were identified for SBP (P = 0.02), DBP (P = 0.002), and MAP (P = 0.003). Sensitivity analyses among participants not taking antihypertensive or glucose-lowering medications revealed similar associations. Our study provided evidence for a potentially causal relationship between leptin and BP among current smokers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential US population impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137:109–18.

    Article  Google Scholar 

  2. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991–1006.

    Article  CAS  Google Scholar 

  3. Simonds SE, Pryor JT, Ravussin E, Greenway FL, Dileone R, Allen AM, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159:1404–16.

    Article  CAS  Google Scholar 

  4. Huby AC, Otvos L, Belin de Chantemèle EJ. Leptin induces hypertension and endothelial dysfunction via aldosterone-dependent mechanisms in obese female mice. Hypertension. 2016;67:1020–8.

    Article  CAS  Google Scholar 

  5. Allison MA, Ix JH, Morgan C, McClelland RL, Rifkin D, Shimbo D, et al. Higher leptin is associated with hypertension: the multi-ethnic study of atherosclerosis. J Hum Hypertens. 2013;27:617–22.

    Article  CAS  Google Scholar 

  6. Sheu WH, Lee WJ, Chen YT. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens. 1999;17:1289–95.

    Article  CAS  Google Scholar 

  7. Kokot F, Adamczak M, Wiecek A, Cieplok J. Does leptin play a role in the pathogenesis of essential hypertension? Kidney Blood Press Res. 1999;22:154–60.

    Article  CAS  Google Scholar 

  8. Schorr U, Blaschke K, Turan S, Distler A, Sharma AM. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens. 1998;16:1475–80.

    Article  CAS  Google Scholar 

  9. Ma D, Feitosa MF, Wilk JB, Laramie JM, Yu K, Leiendecker-Foster C, et al. Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension. 2009;53:473–9.

    Article  CAS  Google Scholar 

  10. Smith W, Schutte R, Huisman HW, Van Rooyen JM, Ware LJ, Fourie CM, et al. Leptin is positively associated with blood pressure in african men with a low body mass index: the SAfrEIC study. Horm Metab Res. 2015;47:145–51.

    CAS  PubMed  Google Scholar 

  11. Schutte R, Huisman HW, Schutte AE, Malan NT. Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study. J Hum Hypertens. 2005;19:535–41.

    Article  CAS  Google Scholar 

  12. Brown RJ, Meehan CA, Gorden P. Leptin does not mediate hypertension associated with human obesity. Cell. 2015;162:465–6.

    Article  CAS  Google Scholar 

  13. Kamimura D, Suzuki T, Wang W, deShazo M, Hall JE, Winniford MD, et al. Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Hypertens Res. 2018;41:629–38.

    Article  CAS  Google Scholar 

  14. Reseland JE, Mundal HH, Hollung K, Haugen F, Zahid N, Anderssen SA, et al. Cigarette smoking may reduce plasma leptin concentration via catecholamines. Prostaglandins, Leukotrienes, Essent Fat Acids. 2005;73:43–9.

    Article  CAS  Google Scholar 

  15. Kryfti M, Dimakou K, Toumbis M, Daniil Z, Hatzoglou C, Gourgoulianis KI. Effects of smoking cessation on serum leptin and adiponectin levels. Tob Induc Dis. 2015;13:30.

    Article  Google Scholar 

  16. Nagayasu S, Suzuki S, Yamashita A, Taniguchi A, Fukushima M, Nakai Y, et al. Smoking and adipose tissue inflammation suppress leptin expression in Japanese obese males: potential mechanism of resistance to weight loss among Japanese obese smokers. Tob Induc Dis. 2012;10:3.

    Article  CAS  Google Scholar 

  17. Hughes K, Leong WP, Sothy SP, Lun KC, Yeo PP. Relationships between cigarette smoking, blood pressure and serum lipids in the Singapore general population. Int J Epidemiol. 1993;22:637–43.

    Article  CAS  Google Scholar 

  18. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension. 2001;37:187–93.

    Article  CAS  Google Scholar 

  19. Li J, Cui R, Eshak ES, Yamagishi K, Imano H, Muraki I, et al. Association of cigarette smoking with radial augmentation index: the Circulatory Risk in Communities Study (CIRCS). Hypertens Res. 2018;41:1054–62.

    Article  CAS  Google Scholar 

  20. Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ, et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol. 2007;165:1328–35.

    Article  Google Scholar 

  21. Kilpeläinen TO, Carli JF, Skowronski AA, Sun Q, Kriebel J, Feitosa MF, et al. Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat Commun. 2016;7:10494.

    Article  Google Scholar 

  22. Beaumont RN, Warrington NM, Cavadino A, Tyrrell J, Nodzenski M, Horikoshi M, et al. Genome-wide association study of offspring birth weight in 86577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics. Hum Mol Genet. 2018;27:742–56.

  23. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. A global reference for human genetic variation. Nature. 2015; 526:68–74.

  24. Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284–7.

    Article  CAS  Google Scholar 

  25. Andersson C, Lyass A, Larson MG, Robins SJ, Vasan RS. Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study. Diabetologia. 2015;58:2774–80.

    Article  CAS  Google Scholar 

  26. Zachariah JP, Quiroz R, Nelson KP, Teng Z, Keaney JF, Sullivan LM, et al. Prospective relation of circulating adipokines to incident metabolic syndrome: the Framingham Heart Study. J Am Heart Assoc. 2017;6.

  27. von Jeinsen B, Short MI, Xanthakis V, Carneiro H, Cheng S, Mitchell GF, et al. Association of circulating adipokines with echocardiographic measures of cardiac structure and function in a community-based cohort. J Am Heart Assoc. 2018;7.

  28. Li C, Kim YK, Dorajoo R, Li H, Lee IT, Cheng CY, et al. Genome-wide association study meta-analysis of long-term average blood pressure in East Asians. Circ Cardiovasc Genet. 2017;10:e001527.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Li C, He J, Chen J, Zhao J, Gu D, Hixson JE, et al. Genome-wide gene-potassium interaction analyses on blood pressure: the GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity). Circ Cardiovasc Genet. 2017;10.

  30. Kannel WB, Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med. 1979;139:857–61.

    Article  CAS  Google Scholar 

  31. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91.

    Article  Google Scholar 

  32. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60.

    Article  Google Scholar 

  33. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA. 1999;282:1568–75.

    Article  CAS  Google Scholar 

  34. Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R, et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA. 1997;94:7001–5.

    Article  CAS  Google Scholar 

  35. Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab. 2009;297:E1247–59.

    Article  CAS  Google Scholar 

  36. Tu H, Kastin AJ, Hsuchou H, Pan W. Soluble receptor inhibits leptin transport. J Cell Physiol. 2008;214:301–5.

    Article  CAS  Google Scholar 

  37. Pan W, Kastin AJ. Adipokines and the blood-brain barrier. Peptides. 2007;28:1317–30.

    Article  CAS  Google Scholar 

  38. Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen AA, Al Sharafi A, Abdella N. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Ann Nutr Metab. 2008;52:329–34.

    Article  CAS  Google Scholar 

  39. Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64:24–34.

    Article  CAS  Google Scholar 

  40. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, et al. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes. 2011;60:1329–39.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, 120 B.S. Miller Hall, Health Sciences Campus, 101 Buck Road, Athens, GA, 30602, USA

    Luqi Shen, José F. Cordero, Ye Shen, Ruiyuan Zhang & Changwei Li

  2. Department of Environmental Health Science, College of Public Health, University of Georgia, 150 East Green Street, Athens, GA, 30602, USA

    Jia-Sheng Wang

  3. Department of Health Care Administration, College of Health and Human Services, California State University, Long Beach, 1250 Bellflower Blvd, Long Beach, CA, 90840, USA

    Yanling Qi

Authors
  1. Luqi Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. José F. Cordero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jia-Sheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ye Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruiyuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yanling Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Changwei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Changwei Li.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shen, L., Cordero, J.F., Wang, JS. et al. The effect of leptin on blood pressure considering smoking status: a Mendelian randomization study. Hypertens Res 43, 342–349 (2020). https://doi.org/10.1038/s41440-019-0376-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-019-0376-6

Keywords

Search

Advanced search

Quick links